Marks Electrical Group PLC 43.2% potential upside indicated by Canaccord Genuity

Marks Electrical Group PLC with ticker (LON:MRK) now has a potential upside of 43.2% according to Canaccord Genuity.



Canaccord Genuity set a target price of 100 GBX for the company, which when compared to the Marks Electrical Group PLC share price of 70 GBX at opening today (26/04/2024) indicates a potential upside of 43.2%. Trading has ranged between 65 (52 week low) and 110 (52 week high) with an average of 39,465 shares exchanging hands daily. The market capitalisation at the time of writing is £75,563,280.

Merck & Co., Inc. is a global health care company. It offers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. The Company’s Pharmaceutical segment includes human health pharmaceuticals and vaccine products. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. It sells these human health pharmaceutical products to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, and health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. The Company’s lead candidate, MK-6070, is a T-cell engager targeting delta-like ligand 3 (DLL3), an inhibitory canonical Notch ligand.